These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21633025)

  • 21. Influence of food on the pharmacokinetic profile of fesoterodine.
    Malhotra B; Sachse R; Wood N
    Int J Clin Pharmacol Ther; 2009 Jun; 47(6):384-90. PubMed ID: 19473600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sitamaquine sensitivity in Leishmania species is not mediated by drug accumulation in acidocalcisomes.
    López-Martín C; Pérez-Victoria JM; Carvalho L; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4030-6. PubMed ID: 18794384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The minimal impact of food on the pharmacokinetics of ridaforolimus.
    Stroh M; Li X; Marsilio S; Panebianco D; Johnson-Levonas A; Juan A; Orford K; Agrawal N; Trucksis M; Wagner JA; Murphy G; Iwamoto M
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):177-82. PubMed ID: 22669570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visceral leishmaniasis with concomittant post kala-azar dermal leishmaniasis responds to oral sitamaquine: case report.
    Mbui J; Rashid R; Lodenyo H; Nyakundi P; Kipmutai R; Mutuma G; Kirigi G; Kinoti D; Wasunna M
    East Afr Med J; 2003 Aug; 80(8):440-2. PubMed ID: 14601788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects.
    Patel MR; Kansagra KA; Parikh DP; Parmar DV; Patel HB; Soni MM; Patil US; Patel HV; Patel JA; Gujarathi SS; Parmar KV; Srinivas NR
    Clin Drug Investig; 2018 Jan; 38(1):57-65. PubMed ID: 29022212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid).
    Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Kovācs P; Stoeckel K; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():18-23. PubMed ID: 21443600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
    Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India.
    Pandey K; Pal B; Siddiqui NA; Rabi Das VN; Murti K; Lal CS; Verma N; Babu R; Ali V; Kumar R; Das P
    Am J Trop Med Hyg; 2017 Nov; 97(5):1498-1502. PubMed ID: 29016288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.
    Martínez-Sellés M; Datino T; Figueiras-Graillet L; Gama JG; Jones C; Franklin R; Fernández-Avilés F
    Clin Drug Investig; 2013 Jan; 33(1):45-54. PubMed ID: 23184666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compassionate use of sitamaquine in an HIV-positive patient with visceral leishmaniasis.
    Rashid JR; Nyakundi PM; Kirigi G; Kinoti D; Wasunna MK
    Trans R Soc Trop Med Hyg; 2002; 96(5):533-4. PubMed ID: 12474482
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes.
    Dueñas-Romero AM; Loiseau PM; Saint-Pierre-Chazalet M
    Biochim Biophys Acta; 2007 Feb; 1768(2):246-52. PubMed ID: 16945323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
    Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
    Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
    Goyal V; Das VNR; Singh SN; Singh RS; Pandey K; Verma N; Hightower A; Rijal S; Das P; Alvar J; Bern C; Alves F
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008429. PubMed ID: 32687498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India.
    Sinha PK; Roddy P; Palma PP; Kociejowski A; Lima MA; Rabi Das VN; Gupta J; Kumar N; Mitra G; Saint-Sauveur JF; Seena S; Balasegaram M; Parreño F; Pandey K
    Am J Trop Med Hyg; 2010 Aug; 83(2):357-64. PubMed ID: 20682882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.